Overview
Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipients
Status:
Unknown status
Unknown status
Trial end date:
2018-02-01
2018-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The investigators expect to better characterise B cell subpopulation and functional properties early after graft, to analyse effect of induction therapy (thymoglobulin versus basiliximab) on B cells, and to compare this B cell profiles with those obtained in our previous study in patients with chronic Antibody Mediated Rejection (cAMR)Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University Hospital, BrestTreatments:
Antibodies, Monoclonal
Basiliximab
Thymoglobulin
Criteria
Inclusion Criteria:- Age >18 years old
- Recipient of a renal allograft
- Patient receiving either basiliximab or thymoglobulin as in induction therapy for
renal transplant
- Patient presenting a low immunologic risk
- Patient not opposed to his (her) study participation
Exclusion Criteria:
- Patient participating in a clinical trial